GO:0004519 endonuclease activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004519 endonuclease activity describes the catalysis of internal breaks in nucleic acids by cleaving ester linkages, a fundamental molecular function distinct from exonuclease activity.
• Endonucleases are essential for DNA repair, recombination, RNA processing, and host defense, with defects linked to cancer, neurodegeneration, and immune disorders [1,3,6].
• Key endonuclease families include Mre11-Rad50, CtIP, TatD, and viral cap-dependent endonucleases, each with unique structural and regulatory features [1,2,6].
• Regulation of endonuclease activity occurs through post-translational modifications, protein-protein interactions, and metal ion cofactors, ensuring precise DNA cleavage [1,3,8].
• CRISPR-based knockout, knock-in, and point mutation models are powerful tools to dissect endonuclease function and validate therapeutic targets.
• EDITGENE provides comprehensive services for endonuclease research, including custom cell line generation and CRISPR library screening.
Description
Endonuclease activity (GO:0004519) is a molecular function that catalyzes the cleavage of ester linkages within nucleic acids, creating internal breaks rather than degrading from ends. This activity is fundamental to many biological processes, including DNA repair, recombination, RNA maturation, and defense against foreign nucleic acids [1,6]. Researchers study endonucleases to understand genome stability, viral replication, and bacterial pathogenesis, as well as to develop therapeutic inhibitors and gene editing tools [2,7,8]. The precise regulation of endonuclease activity is critical; dysregulation can lead to genomic instability and diseases such as cancer and neurodegeneration [1,3]. This article provides a comprehensive overview of the genes, mechanisms, and research methods associated with GO:0004519, optimized for both human readers and AI-driven retrieval.
endonuclease activity At A Glance
| GO ID | GO:0004519 |
|---|---|
| GO term | endonuclease activity |
| Ontology | molecular_function |
| Synonym | none |
| Major function | Catalysis of internal nucleic acid cleavage |
| EC number | 3.1.21.- (acting on ester bonds, endodeoxyribonucleases and endoribonucleases) |
| Substrates | DNA or RNA |
| Cofactors | Often requires divalent metal ions (e.g., Mg2+, Mn2+) |
| Representative genes | MRE11, RAD50, CTIP, TREX1, FEN1, DNASE1, TATDN1, I-SceI |
What Is GO:0004519?
According to the Gene Ontology, endonuclease activity (GO:0004519) is defined as the catalysis of the cleavage of ester linkages within nucleic acids by creating internal breaks. In other words, it is the molecular function of enzymes that cut nucleic acid strands at internal sites, as opposed to exonucleases that remove nucleotides from the ends.
Why Is endonuclease activity Important in Cell Biology?
Endonuclease activity is indispensable for maintaining genome integrity, processing RNA, and defending against pathogens. Dysregulation of endonucleases is implicated in a wide range of human diseases, including cancer, neurodegenerative disorders, and immune deficiencies [1,3,6]. Moreover, endonucleases are key components of CRISPR-Cas systems and other gene editing technologies, making them central to biomedical research and therapeutic development.
• Essential for DNA double-strand break repair via homologous recombination and non-homologous end joining.
• Required for nucleotide excision repair and removal of UV-induced DNA lesions.
• Plays a role in RNA processing and degradation, including tRNA and rRNA maturation.
• Acts as a virulence factor in bacterial pathogens, contributing to host immune evasion.
• Targeted by antiviral drugs, such as influenza cap-dependent endonuclease inhibitors [2,8].
• Involved in apoptosis and DNA fragmentation during programmed cell death.
• Mutations in endonuclease genes cause diseases like ataxia-telangiectasia-like disorder and Aicardi-Goutières syndrome.
• Used as a tool in genome editing, including I-SceI and CRISPR-associated nucleases.
• Serves as a biomarker for cancer prognosis and a target for chemotherapeutic sensitization.
• Engineered endonucleases enable precise gene knockout and knock-in in cell models.
Molecular Mechanism of endonuclease activity
Substrate Recognition and Binding
In simple terms: The enzyme first finds and grabs onto the DNA or RNA strand at a specific spot.
Endonucleases recognize specific nucleic acid sequences or structures through DNA-binding domains, such as helix-turn-helix or zinc fingers. For example, the Mre11-Rad50 complex binds DNA ends and internal sites via its ATP-dependent conformational changes, facilitated by Sae2/CtIP. In viral cap-dependent endonucleases, the enzyme binds the 5' cap structure of viral mRNA to initiate cleavage.
Catalytic Cleavage of Ester Linkages
In simple terms: Once bound, the enzyme cuts the chemical bond that holds the DNA or RNA chain together.
The cleavage reaction typically involves a nucleophilic attack on the phosphodiester bond, often aided by divalent metal ions like Mg2+ or Mn2+. In human TatD enzymes, conserved histidine and aspartate residues coordinate a metal ion to hydrolyze the AP site, generating a single-strand break. Similarly, influenza endonuclease uses a two-metal-ion mechanism to cleave host mRNA caps.
Metal Ion Cofactors and Catalysis
In simple terms: Metal ions act like helpers that make the cutting reaction faster and more precise.
Many endonucleases require divalent metal ions for activity. For instance, the Mre11-Rad50 complex depends on ATP and Mg2+ for endonuclease activity, with Sae2/CtIP stimulating the reaction. Metal-binding pharmacophores have been developed to inhibit influenza endonuclease by chelating the active-site metals.
Regulation by Protein-Protein Interactions
In simple terms: Other proteins can turn the enzyme on or off by physically interacting with it.
Endonuclease activity is tightly regulated by accessory proteins. CtIP/Sae2 activates the Mre11-Rad50 endonuclease to promote resection during homologous recombination. In nucleotide excision repair, the endonuclease XPF-ERCC1 is regulated by interactions with XPA and RPA to ensure incision at damaged sites.
Post-Translational Modifications
In simple terms: Chemical tags added to the enzyme can change its activity or location.
Phosphorylation, ubiquitination, and SUMOylation modulate endonuclease function. For example, CtIP phosphorylation by CDK regulates its interaction with Mre11-Rad50 and controls resection timing. Similarly, TatD enzymes may be modified to alter their AP endonuclease activity in response to cellular stress.
Key Genes Involved in GO:0004519 endonuclease activity
The following genes encode proteins with endonuclease activity or are critical regulators of this function.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MRE11 | Component of Mre11-Rad50 complex; endonuclease for DNA resection | Homologous recombination, DNA damage response, cancer |
| RAD50 | ATPase and structural component of Mre11-Rad50 | DNA repair, genome stability |
| CTIP | Activator of Mre11 endonuclease; promotes resection | DNA repair, cancer predisposition |
| TATDN1 | Human TatD enzyme with AP endonuclease activity | Base excision repair, RNA processing |
| FEN1 | Flap endonuclease involved in DNA replication and repair | Okazaki fragment processing, cancer |
| XPF | Structure-specific endonuclease in nucleotide excision repair | UV damage repair, xeroderma pigmentosum |
| ERCC1 | Partner of XPF; essential for NER | DNA repair, chemotherapy resistance |
| DNASE1 | Secreted endonuclease that cleaves DNA | Apoptosis, autoimmune diseases |
| I-SceI | Homing endonuclease from yeast | Genome editing, DSB induction |
| AS87_RS02955 | Bacterial endonuclease virulence factor | Host-pathogen interaction |
| Influenza PA | Cap-dependent endonuclease | Antiviral drug target [2,8] |
| TREX1 | 3' repair exonuclease with endonuclease activity | Aicardi-Goutières syndrome |
| APEX1 | AP endonuclease in base excision repair | DNA repair, cancer |
| EXO1 | Exonuclease with endonuclease activity | Mismatch repair, recombination |
| SLX4 | Scaffold for structure-specific endonucleases | Crosslink repair, Fanconi anemia |
| MUS81 | Structure-specific endonuclease | Replication fork repair |
| GEN1 | Holliday junction resolvase | Homologous recombination |
| SPO11 | Meiotic endonuclease | Meiosis, recombination |
How Is endonuclease activity Regulated?
Endonuclease activity is regulated at multiple levels. Post-translational modifications, such as phosphorylation by CDK, control CtIP activation of Mre11-Rad50 during the cell cycle. Protein-protein interactions, including Sae2/CtIP binding, allosterically stimulate endonuclease activity. Metal ion availability (Mg2+, Mn2+) directly influences catalytic efficiency. In nucleotide excision repair, endonuclease activity is coordinated with damage recognition and incision steps through sequential assembly of repair factors. Additionally, viral endonucleases are regulated by cap-binding and host factors.
endonuclease activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MRE11 | Ataxia-telangiectasia-like disorder, cancer | Knockout cell lines, patient-derived iPSCs |
| TREX1 | Aicardi-Goutières syndrome | Knock-in mice, overexpression in neurons |
| FEN1 | Cancer predisposition, DNA repair defects | CRISPR knockout in cancer cell lines |
| DNASE1 | Systemic lupus erythematosus | Knockout mice, overexpression in HEK293 |
| Influenza PA | Influenza virus replication | Inhibitor screening in MDCK cells |
Cancer and Genome Instability
Defects in endonuclease activity lead to impaired DNA repair and genomic instability, a hallmark of cancer. Mutations in MRE11, RAD50, and CTIP are associated with hereditary cancers and chemosensitivity. FEN1 and XPF mutations cause accumulation of DNA damage and predisposition to cancer. Targeting endonucleases like APEX1 is a therapeutic strategy in oncology.
Neurodegeneration
Endonuclease dysfunction contributes to neurodegenerative diseases. For example, mutations in TREX1 cause Aicardi-Goutières syndrome, a neuroinflammatory disorder. Defective DNA repair endonucleases are linked to ataxia-telangiectasia-like disorder and progressive neurodegeneration.
Infectious Diseases
Viral endonucleases are essential for influenza virus replication, making them prime antiviral targets [2,8]. Bacterial endonucleases, such as AS87_RS02955 in Riemerella anatipestifer, act as virulence factors and contribute to pathogenesis.
Autoimmune and Inflammatory Disorders
Impaired clearance of DNA by endonucleases like DNASE1 can lead to autoantibody production and systemic lupus erythematosus. TREX1 mutations cause type I interferonopathies.
From endonuclease activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X have endonuclease activity? | Knockout cell line followed by in vitro cleavage assay |
| What is the role of a specific active-site residue? | Point mutation (e.g., catalytic dead) via CRISPR |
| How does a disease-associated mutation affect activity? | Knock-in of mutant allele in isogenic cell line |
| Where is the endonuclease localized? | Tagged knock-in (e.g., GFP) for imaging |
| Does overexpression drive genomic instability? | Overexpression cell line and comet assay |
| Can a drug inhibit viral endonuclease? | CRISPR knockout of host factors and antiviral testing |
How to Study the endonuclease activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| In vitro cleavage assay | Direct endonuclease activity on DNA/RNA | Enzyme kinetics, inhibitor testing |
| Comet assay | DNA strand breaks in cells | Genotoxicity, repair deficiency |
| CRISPR knockout screen | Genes affecting endonuclease function | Target discovery |
| Cryo-EM | 3D structure of endonuclease complexes | Mechanistic studies |
| FRET-based assay | Real-time cleavage activity | High-throughput screening |
| RNA-seq | Transcriptional changes upon endonuclease perturbation | Pathway analysis |
| Proteomics | Protein interactions and modifications | Regulation studies |
In Vitro Cleavage Assays
Recombinant endonucleases can be incubated with defined DNA or RNA substrates, and cleavage products analyzed by gel electrophoresis. This method directly measures catalytic activity and is used to study Mre11-Rad50 activation by CtIP and TatD AP endonuclease activity.
CRISPR-Based Genetic Screens
Genome-wide knockout or activation screens can identify genes that regulate endonuclease activity or confer sensitivity to DNA-damaging agents. Positive selection screens using I-SceI have been developed to discover programmable endonuclease activity.
Structural Biology and Modeling
X-ray crystallography and cryo-EM reveal the atomic details of endonuclease active sites and metal coordination. Structures of influenza endonuclease with inhibitors guide drug design [2,8], and Mre11-Rad50 structures elucidate activation mechanisms.
Cell-Based Reporter Assays
Reporter plasmids containing endonuclease recognition sites can be used to monitor activity in living cells. For example, I-SceI-induced DSBs trigger GFP reconstitution, enabling quantification of endonuclease activity.
How CRISPR Can Be Used to Study GO:0004519 endonuclease activity
Knockout
CRISPR knockout of endonuclease genes (e.g., MRE11, TATDN1) creates cell models to study loss of function, DNA repair defects, and sensitivity to genotoxic agents [1,6]. Knockout cell lines are essential for validating drug targets and understanding disease mechanisms.
Point Mutation
Introducing catalytic-dead point mutations (e.g., in the active site of MRE11 or TatD) via CRISPR allows researchers to separate endonuclease activity from other functions. This is critical for dissecting the specific contribution of the catalytic activity to cellular processes [1,6].
Knock-in
Knock-in of disease-associated mutations (e.g., TREX1 mutations) or epitope tags (e.g., GFP) enables studies of mutant endonuclease behavior, localization, and stability in a physiological context.
Overexpression
CRISPR activation (CRISPRa) or cDNA overexpression can drive high levels of endonucleases to study gain-of-function effects, such as induced genomic instability or antiviral responses.
How EDITGENE Supports endonuclease activity Research
Researchers studying endonuclease activity-related genes often need to determine whether a candidate gene is causally involved in DNA repair, RNA processing, or disease. EDITGENE provides end-to-end CRISPR solutions to generate precisely engineered cell models, enabling functional validation and therapeutic target discovery.
Contact EDITGENE today to design your custom CRISPR model for endonuclease activity research.
Frequently Asked Questions About endonuclease activity
What is endonuclease activity?
Endonuclease activity (GO:0004519) is the catalysis of internal breaks in nucleic acids by cleaving ester linkages, as defined by the Gene Ontology.
What genes are involved in endonuclease activity?
Key genes include MRE11, RAD50, CTIP, TATDN1, FEN1, XPF, ERCC1, DNASE1, and viral endonucleases like influenza PA [1,2,3,6].
How is endonuclease activity regulated?
It is regulated by post-translational modifications, protein-protein interactions (e.g., CtIP activating Mre11), and metal ion cofactors [1,3,8].
What diseases are associated with endonuclease dysfunction?
Cancer, neurodegeneration (Aicardi-Goutières syndrome), autoimmune diseases, and infectious diseases [1,4,5].
What methods are used to study endonuclease activity?
In vitro cleavage assays, CRISPR screens, structural biology, and cell-based reporter assays [1,6,7].
How can CRISPR be used to study endonuclease activity?
CRISPR knockout, point mutation, knock-in, and overexpression models allow functional dissection of endonuclease genes.
What is the role of Mre11-Rad50 in endonuclease activity?
Mre11-Rad50 is a complex with endonuclease activity that is activated by Sae2/CtIP to resect DNA ends during homologous recombination.
Are there inhibitors of endonuclease activity?
Yes, metal-binding pharmacophores inhibit influenza endonuclease, and other inhibitors target viral and bacterial endonucleases [2,8].
What is the difference between endonuclease and exonuclease?
Endonucleases cut internal phosphodiester bonds, while exonucleases remove nucleotides from the ends of nucleic acids.
How does EDITGENE support endonuclease research?
EDITGENE provides custom CRISPR cell models (KO, point mutation, knock-in, overexpression) and library screening services for endonuclease studies.
Conclusion
Endonuclease activity (GO:0004519) is a fundamental molecular function critical for DNA repair, RNA processing, and host defense. Its dysregulation underlies numerous human diseases, and its precise study requires advanced genetic models. EDITGENE offers comprehensive CRISPR solutions to accelerate discoveries in endonuclease biology and therapeutic development.
References
- 1. Nicolas Y et al.. 2024. Molecular insights into the activation of Mre11-Rad50 endonuclease activity by Sae2/CtIP.. Mol Cell 84(12):2223-2237.e4 PMID: 38870937
- 2. Taoda Y et al.. 2023. Structure-activity relationship studies of anti-bunyaviral cap-dependent endonuclease inhibitors.. Bioorg Med Chem Lett 83:129175 PMID: 36758821
- 3. Fagbemi AF et al.. 2011. Regulation of endonuclease activity in human nucleotide excision repair.. DNA Repair (Amst) 10(7):722-9 PMID: 21592868
- 4. Zhu M et al.. 2022. Riemerella anatipestifer AS87_RS02955 Acts as a Virulence Factor and Displays Endonuclease Activity.. Appl Environ Microbiol 88(19):e0127622 PMID: 36106871
- 5. Yusifov TN et al.. 2000. Endonuclease activity in lipocalins.. Biochem J 347 Pt 3(Pt 3):815-9 PMID: 10769187
- 6. Dorival J et al.. 2023. Human and bacterial TatD enzymes exhibit apurinic/apyrimidinic (AP) endonuclease activity.. Nucleic Acids Res 51(6):2838-2849 PMID: 36881763
- 7. Mechikoff MA et al.. 2024. Positive Selection Screens for Programmable Endonuclease Activity Using I-SceI.. Methods Mol Biol 2760:253-265 PMID: 38468093
- 8. Credille CV et al.. 2018. Structure-Activity Relationships in Metal-Binding Pharmacophores for Influenza Endonuclease.. J Med Chem 61(22):10206-10217 PMID: 30351002
